Rituximab Intolerance in Patients With Waldenström Macroglobulinaemia

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.13794
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

How We Manage Patients With Waldenström Macroglobulinaemia

British Journal of Haematology
Hematology
2018English

Long Survival in Patients With Waldenström Macroglobulinaemia Diagnosed at a Young Age

British Journal of Haematology
Hematology
2018English

Bendamustine Plus Rituximab in Newly‐diagnosed Waldenström Macroglobulinaemia Patients. A Study on Behalf of the French Innovative Leukaemia Organization (FILO)

British Journal of Haematology
Hematology
2018English

Recommendations for the Diagnosis and Initial Evaluation of Patients With Waldenström Macroglobulinaemia: A Task Force From the 8th International Workshop on Waldenström Macroglobulinaemia

British Journal of Haematology
Hematology
2016English

Importance of Sequential Analysis of TP 53 Variation in Patients With Waldenström Macroglobulinaemia

British Journal of Haematology
Hematology
2019English

Comparative Outcomes of Immunochemotherapy Regimens in Waldenström Macroglobulinaemia

British Journal of Haematology
Hematology
2017English

Waldenström Macroglobulinaemia Terminating in Acute Lymphoblastic Leukaemia After Treatment With Fludarabine

British Journal of Haematology
Hematology
2018English

Prevalence and Survival of Smouldering Waldenström Macroglobulinaemia in the United States

British Journal of Haematology
Hematology
2018English

PATIENT-REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB-RITUXIMAB IN THE INNOVATE STUDY

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy